Latest Health News

EQ Resources has finalized a US$7.5 million royalty funding agreement with Oaktree Capital Management to support its Barruecopardo tungsten project, while major shareholder Cronimet Asia converts a US$3 million offtake prepayment into equity, strengthening the company’s capital position.

Amcor has completed its transformative acquisition of Berry Global, reporting a 43% jump in quarterly net sales and projecting strong earnings growth for fiscal 2026. The company’s strategic portfolio review and synergy realisation efforts underpin an optimistic outlook.

Cochlear Limited reported a solid FY25 with 4% revenue growth and a 1% rise in underlying profit, underpinned by new product launches and expanding evidence linking implants to reduced dementia risk. The company’s FY26 outlook signals further gains as it advances market leadership and innovation.

Cochlear Limited reported a 4% revenue rise in FY25, driven by strong implant sales and launched the world’s first smart cochlear implant system. The company forecasts up to 17% profit growth in FY26, underpinned by innovation and expanding markets.

Cochlear Limited has announced a fully franked ordinary dividend of AUD 2.15 per share for the six months ending June 2025, payable in October with multi-currency options for shareholders.

HealthCo Healthcare & Wellness REIT reports FY25 results marked by suspended distributions amid Healthscope receivership, while maintaining strong portfolio fundamentals and active tenant resolution efforts.

ECP Emerging Growth Limited reported a net loss for FY2025, with portfolio returns lagging the ASX Small Ordinaries Index, yet the company maintains confidence in its long-term strategy and declared a fully franked dividend.

TALi Digital Limited reported a sharp reduction in losses for FY25 alongside a strategic acquisition of YCDI Education Australia, signaling a pivot towards social-emotional learning. The company also secured nearly $1 million in fresh capital to support its growth ambitions.

HiTech Group Australia Limited has reported solid growth in revenue and net profit for FY25, underpinned by strong demand in ICT recruitment and contracting services. The company also declared a fully franked 5 cent dividend, reflecting confidence in its financial position.

Pro Medicus has delivered a landmark FY25 with soaring revenue and profit, driven by major contract wins and strategic cloud deployments. The company’s expanding North American footprint and AI initiatives set the stage for sustained growth.

Pro Medicus Limited reports a record-breaking year with $520 million in new contracts and a surge in cloud adoption, setting the stage for continued growth. The company also advances its AI and cardiology offerings, reinforcing its market position.

Pro Medicus Limited has announced a fully franked ordinary dividend of AUD 0.30 per share for the fiscal year ending June 30, 2025, signaling steady returns for shareholders.